Sohini Das, Sundar Sethuraman

Stories by Sohini Das, Sundar Sethuraman

Young Buyers Power Lamborghini's India Drive

Young Buyers Power Lamborghini's India Drive

Rediff.com   31 Mar 2025

India ranks 6th in the Asia-Pacific region for the Italian super luxury carmaker.

Despite market volatility, corporate fundraising at record high in FY25

Despite market volatility, corporate fundraising at record high in FY25

Rediff.com   28 Mar 2025

Fundraising by Indian companies through equity and debt reached an all-time high in the financial year 2024-25 (FY25), according to data collated by primedatabase.com. Fundraising through debt stood at Rs 11.1 trillion in FY25, including contributions from InvITs (infrastructure investment trusts) and REITs (real estate investment trusts).

D-Street puts up best weekly showing in years

D-Street puts up best weekly showing in years

Rediff.com   22 Mar 2025

The equity benchmark indices posted their strongest weekly gains in years, driven by bargain hunting and optimism over a reversal in foreign portfolio investor (FPI) outflows. The Sensex rose 558 points, or 0.7 per cent, on Friday to close at 76,906, while the Nifty 50 gained 160 points to end at 23,350. Over the past five sessions, both indices advanced around 4.3 per cent - marking the Sensex's best weekly performance since July 22, 2022, and the Nifty 50's strongest rally since February 5, 2021.

Discounts are back at car dealerships

Discounts are back at car dealerships

Rediff.com   21 Mar 2025

Dealers said the discounts this March are higher than the same month in the previous year.

PV Sales Face Bleak Outlook in 2024-25

PV Sales Face Bleak Outlook in 2024-25

Rediff.com   20 Mar 2025

Major Indian carmakers are preparing for sluggish domestic PV sales growth of just 1-2 per cent in FY26.

The Magnificent 7: FPIs' Wild Ride In Selloff

The Magnificent 7: FPIs' Wild Ride In Selloff

Rediff.com   20 Mar 2025

Since October, FPIs have offloaded Indian equities worth Rs 2.1 trillion.

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com   20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

For Tesla, India is a challenge as well as opportunity

For Tesla, India is a challenge as well as opportunity

Rediff.com   19 Mar 2025

With India's EV penetration at just 2.5 per cent, the market presents an opportunity -- provided Tesla gets its pricing right.

'Scale Of Wealth Destruction Is Sudden And Sweeping'

'Scale Of Wealth Destruction Is Sudden And Sweeping'

Rediff.com   12 Mar 2025

618 companies were part of the billion dollar club when the markets reached all-time highs on September 26, 2024. That number has fallen to 500 following a $1 trillion wipeout in India's market capitalisation amid relentless selling by FPIs.

From Tesla to Mercedes, luxury carmakers head South

From Tesla to Mercedes, luxury carmakers head South

Rediff.com   11 Mar 2025

In 2024 alone, South India saw the highest rise in sales in the luxury segment, with Tamil Nadu reportedly registering a 19.3 per cent increase in premium car registrations from 2022-23

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com   8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

'US tariff issue is an overhanging sword'

'US tariff issue is an overhanging sword'

Rediff.com   7 Mar 2025

Firodia talked about his plans for the EV-components business, and the components business at large for the group

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com   6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Can Tesla Make In India For Below $23,000?

Can Tesla Make In India For Below $23,000?

Rediff.com   5 Mar 2025

The Indian automotive market offers around 1 million units annual volume opportunity at a price above $23,000.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com   27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

'Capital is flowing back to the US'

'Capital is flowing back to the US'

Rediff.com   27 Feb 2025

'Even if India is attractive, FPIs currently lack the funds to invest, as money is being redirected to the US.'

Rs 50K cr shares to unlock soon; sellers may sweat

Rs 50K cr shares to unlock soon; sellers may sweat

Rediff.com   25 Feb 2025

Shares worth over Rs 50,000 crore (or approximately $6 billion) are set to become freely tradable between now and April 10. Historically, such substantial volumes have been absorbed by a buoyant block-deal market.

Nifty May End In Red For Record 5th Month

Nifty May End In Red For Record 5th Month

Rediff.com   25 Feb 2025

The last time this happened was in 1996.

Why Tesla Entry is No Major Threat

Why Tesla Entry is No Major Threat

Rediff.com   24 Feb 2025

Tesla needs to either sell the same models with reduced features to lower the cost for Indian market, or incur losses.

New Stocks Sink Below Issue Price

New Stocks Sink Below Issue Price

Rediff.com   20 Feb 2025

On average, stocks that debuted last year are down 37 per cent from their peak levels.